Company News Pharmaceutical Industry News
No business can ignore their Carbon Footprint, nor their responsibilities to achieve Net Zero carbon emissions. At ALLpaQ, we believe […]
Nov 16th, 2022
Nov 16th, 2022
Press Release: Medi-Tech Insights
The Global Single-use Assemblies Market, which was valued at $2.25 billion in 2021, is set to grow 22% over the next 5 years to reach $6.1 Billion by 2026.
Key factors accelerating the Single-use Assemblies Market include the advantage of ready-to-use assemblies, funding for single-use manufacturing, a buoyant biologics and vaccines market, and increasing biopharmaceutical research and development.
A single-use assembly is a ready-to-use custom-made solution which comprises a range of plastic components assembled into one whole, based on a customer-specific design.
Bioprocessing end users usually undertake the in-house assembling of single-use systems. If connections between the different components are not made correctly, it might result in cross-contamination and leakage which in turn might lead to production delays. Ready-to-use single-use assemblies aptly address these issues.
Some of the key benefits, include:
The elimination of cleaning and downtime are also among the advantages that are bolstering single-use assemblies market demand
Favourable funding for single-use solutions manufacturing is also identified as a trigger factor in the growth of single-use assemblies market. Over the past 10 years, single-use assemblies and technologies have seen a significant adoption across the world.
Integrating single-use equipment into bioprocessing:
A single-use assembly provides everything a bio processor requires: bags, tubing, connectors, and filters. It provides flexible, customized single-use solutions to accelerate pharmaceutical drug development and manufacturing. Ready-to-use assemblies allow the development and production of products in a wide range of sizes and for a variety of diseases.
It is a critical component in the supply chain for the production of vaccines and medications around the world.
The global single-use assemblies market is marked by the presence of major industry players such as Thermo Fisher Scientific, Inc., Sartorius Stedim Biotech, Danaher Corporation, Merck KGaA, Avantor, Inc., Saint-Gobain, and others.